Pharmatech Inc.

TrialPlus+, introduced on August 1st, was developed for research sites and physicians to be able to access a broad range of clinical trials that are available for their centers.

Pharmatech and Weill Cornell Medical College agreed to evaluate an innovative, rapid approach to identifying and enrolling patients under a Phase II Small Business Innovative Research grant funded by the National Cancer Institute.

Pharmatech Inc. wrapped up their first productive year of their Small Business Innovative Research (SBIR)/ National Cancer Institute grant R44CA144362: A Patient-Centered Approach to Enrolling Rare Cancer Patients in Clinical Trials, in July, 2013.